Abstract
A study on the activity of cefaclor and cephalexin against clinical bacterial isolates is presented. Bacteria tested include Staphylococcus aureus, S. epidermidis, enterococcus, Escherichia coli, Enterobacter sp., Serratia marcescens, Proteus mirabilis and Pseudomonas aeruginosa.

This publication has 1 reference indexed in Scilit: